Cargando…
Evaluation of Na(v)1.8 as a therapeutic target for Pitt Hopkins Syndrome
Pitt Hopkins Syndrome (PTHS) is a rare syndromic form of autism spectrum disorder (ASD) caused by autosomal dominant mutations in the Transcription Factor 4 (TCF4) gene. TCF4 is a basic helix-loop-helix transcription factor that is critical for neurodevelopment and brain function through its binding...
Autores principales: | Martinowich, Keri, Das, Debamitra, Sripathy, Srinidhi Rao, Mai, Yishan, Kenney, Rakaia F., Maher, Brady J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812766/ https://www.ncbi.nlm.nih.gov/pubmed/36224259 http://dx.doi.org/10.1038/s41380-022-01811-4 |
Ejemplares similares
-
Promyelinating drugs promote functional recovery in an autism spectrum disorder mouse model of Pitt–Hopkins syndrome
por: Bohlen, Joseph F, et al.
Publicado: (2023) -
Generation of 10 patient-specific induced pluripotent stem cells (iPSCs) to model Pitt-Hopkins Syndrome
por: Sripathy, S.R., et al.
Publicado: (2020) -
A myelin-related transcriptomic profile is shared between Pitt Hopkins syndrome models and human autism spectrum disorder
por: Phan, BaDoi N., et al.
Publicado: (2020) -
Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression
por: Cleary, C. M., et al.
Publicado: (2021) -
Neurodevelopmental models of transcription factor 4 deficiency converge on a
common ion channel as a potential therapeutic target for Pitt Hopkins
syndrome
por: Rannals, Matthew D., et al.
Publicado: (2016)